Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2022. Start Trial.
Date Value
October 28, 2026 0.299
October 27, 2026 0.3127
October 26, 2026 0.3177
October 23, 2026 0.3171
October 22, 2026 0.3281
October 21, 2026 0.3396
October 20, 2026 0.3402
October 19, 2026 0.3078
October 16, 2026 0.3292
October 15, 2026 0.3819
October 14, 2026 0.3561
October 13, 2026 0.304
October 12, 2026 0.3303
October 09, 2026 0.2837
October 08, 2026 0.3226
October 07, 2026 0.3199
October 06, 2026 0.35
October 05, 2026 0.4027
October 02, 2026 0.4324
October 01, 2026 0.4998
September 30, 2026 0.5827
September 29, 2026 0.5692
September 28, 2026 0.6502
September 25, 2026 0.8043
September 24, 2026 0.817
Date Value
September 23, 2026 0.614
September 22, 2026 0.7764
September 21, 2026 0.5168
September 18, 2026 0.1564
September 17, 2026 0.1635
September 16, 2026 0.1643
September 15, 2026 0.1706
September 14, 2026 0.1789
September 11, 2026 0.1728
September 10, 2026 0.2096
September 09, 2026 0.2299
September 08, 2026 0.2387
September 04, 2026 0.2612
September 03, 2026 0.2458
September 02, 2026 0.2672
September 01, 2026 0.2551
August 31, 2026 0.2661
August 28, 2026 0.2677
August 27, 2026 0.2886
August 26, 2026 0.2765
August 25, 2026 0.5328
August 24, 2026 0.4691
August 21, 2026 0.5561
August 20, 2026 0.4554
August 19, 2026 0.5665

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Tenax Therapeutics, Inc. 0.5246
Exicure, Inc. 6.133
Century Therapeutics, Inc. 1.131
Absci Corp. 8.434
Celularity, Inc. --

Price to Book Value Related Metrics

Price 5.165
Earnings Yield -236.2%
Market Cap 16.41M